The kick off meeting of the project took place on 10th and 11th of February 2016 at Vicomtech-IK4, with the participation of all the partners to pool objectives and work dynamics.
The DESIREE project will provide a decision support system for use in Breast Units to apply specific therapies for each patient depending on the diagnosis.
Donostia - San Sebastian, 9th of February of 2016. Breast cancer is the most common tumour in European women. A large volume of breast cancer related data has accumulated as a result of diagnostic tests and treatments. These data contains valuable information which, if utilised properly and sufficiently, may support early diagnosis and better treatment of new patients. Due to the fast introduction of digital technologies in medicine in recent years, the available information has outgrown the analytical capacity, a challenge that can be addressed by computer vision based tools.
An EU Horizon 2020 funded project, Decision Support and Information Management System for Breast Cancer (DESIREE), undertaken by an international consortium of companies, research centres, universities and hospitals coordinated by Vicomtech-IK4, will address this challenge by developing technologies that bring together all information and process it accurately, smartly and in a multidisciplinary fashion. The technologies will be integrated into a web-based system that accelerates the management of all available information of breast cancer cases, provides a more customised and holistic view of the patient, obtains new evidence based on accumulated and collaborative experiences, and provides agile, intuitive and visual tools for clinical decision support. In particular, the DESIREE project aims at developing tools for the prognosis and evolution of the clinical treatment based on images, allowing to predict the evolution of the breast cancer through non-invasive techniques (mammography, magnetic resonance, digital tomosynthesis, etc.). Moreover, an innovative technology will be developed simulating the breast surgery process based on the physiological model, which will predict the aesthetic result of the surgery and will have important implications in the interaction of the doctor with the patient and in the decision making of the patient.
The project intends to be an international benchmark in the efficient use of medical digital data of any kind with the aim of improving the clinical breast cancer practice.
On 10th and 11th of February the project partners gathered at Vicomtech-IK4 with the aim of pooling experiences and starting this ambitious project. Spanish partners such as Onkologikoa and Bilbomatica in the Basque Country and companies such as Eresa and Sistemas Genómicos with their headquarters in Valencia are part of the project. Other partners include major hospitals in Paris and Houston and several universities, European research centres and SMEs: Arivis, Assistance Publique – Hopitaux de Paris (in particular Hospital de Tenon), Institut National de la Santé et de la Recherche Medicale, Medical Innovation and Technology, Ulster University and University of Houston.
This research and innovation project led by Vicomtech-IK4 started in February 2016 and has a duration of 36 months. DESIREE has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 690238.
